Mucopolysaccharidoses
-
Upload
saad-alani -
Category
Health & Medicine
-
view
377 -
download
0
Transcript of Mucopolysaccharidoses
Mucopolysaccharidoses
Prof. Dr. Saad S Al Ani
Senior Pediatric Consultant
Head of Pediatric Department
Khorfakkan Hospital
Sharjah ,UAE
Mucopolysaccharidoses
Hereditary, progressive diseases caused by
mutations of genes coding for lysosomal
enzymes needed to degrade glycosaminoglycans
(GAGs) (acid mucopolysaccharides).
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital2
Glycosaminoglycan(GAG)
A long-chain complex
carbohydrate composed
of:
1. Uronic acids
2. Amino sugars
3. Neutral sugars.
www.mun.ca
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital3
Glycosaminoglycans(GAGs)
The major GAGs are:
1. Chondroitin -4- sulfate
2. Chondroitin -6- sulfate
3. Heparan sulfate
4. Dermatan sulfate
5. Keratan sulfate
6. Hyaluronan
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital4
Glycosaminoglycans (GAGs) (cont.)
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital5
Major constituents of the ground substance of connective
tissue, as well as nuclear and cell membranes
Proteoglycans degradation
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital6
www.glycoforum.gr.jp
Proteoglycans
Protein coreProteolytic
Stepwise
degradation GAG moiety
Proteoglycans degradation disturbance
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital7
Absent or grossly reduced activity
of mutated lysosomal enzymes
Proteoglycans
Glycosaminoglycans (GAGs) Intralysosomal
Proteoglycans degradation disturbance(cont.)
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital8
printablecolouringpages.co.uk
Distended
lysosomes
cell
function
Characteristic pattern of clinical, radiologic, and
biochemical abnormalities
Specific diseases can be recognized that evolve from the
intracellular accumulation of different degradation products
Rule of fingers
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital9
Heparan sulfate(impaired degradation)
Mental
deficiency
Dermatan sulfate,
Chondroitin
sulfates,
Keratan sulfate
(impaired degradation)
Mesenchymal
abnormalities
Mucopolysaccharidoses
Mucopolysaccharidoses are autosomal recessive
disorders, with the exception of Hunter disease,
which is X- linked recessive.
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital10
Mucopolysaccharidoses (cont.)
Overall frequency is between
3.5/100,000 and 4.5/100,000
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital11
teamsanfilippo.org
http://dxline.info/
Diseases /hurler-
syndrome
flipper.diff.org
The most common subtype is
Sanfilippo disease (MPS-III)
followed by Hurler disease
( MPS-I )
And Hunter disease (MPS II
Sanfilippo Syndrome(MPSIII)
A deficiency in one of the enzymes required to
break down glycosaminoglycan heparan sulfate
(found on the cell surface glycoproteins and
also in extra-cellular matrix)
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital12
http://www.primehealthchannel.com/sanfilippo-syndrome
A rare form of lysosomal storage disease
Inherited in an autosomal recessive pattern
www.primehealthchannel.com
Sanfilippo Syndrome (cont.)
• The incidence vary geographically, One per:
- 50000 people in the Netherlands
- 66000 people in Australia
- 280000 cases in Northern Ireland
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital13
http://www.primehealthchannel.com/sanfilippo-syndrome
www.internationalstudentinsurance.com
www.gapyear.com
www.carhirecomparison.ie
Sanfilippo Syndrome (cont.)
Deficiency in one of the four enzymes:
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital14
1. Heparan N- sulfatase (type A)
Sanfilippo Syndrome (cont.)
2.Alpha-N- acetylglucosaminidase (type B)
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital15
Sanfilippo Syndrome (cont.)
3. Acetyl -Co Alpha- glucosaminide
acetyltransferase (type C)
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital16
Sanfilippo Syndrome (cont.)
4.N- acetylglucosamine 6-sulfatase (type D)
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital17
Sanfilippo Syndrome (cont.)
Patients are characterized by slowly progressive,
severe CNS involvement with mild somatic
disease
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital18
Onset of clinical features usually occurs between
2 and 6 yr in a child who previously appeared
normal.
Sanfilippo Syndrome (cont.)
Presenting features include:
– Delayed development
– Hyperactivity with aggressive behavior
– Coarse hair
– Hirsutism
– Sleep disorders
– Mild hepatosplenomegaly
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital19
articleactive.com
Sanfilippo Syndrome (cont.)
Severe neurologic deterioration occurs in mostpatients by 6-10 yr of age, accompanied by rapiddeterioration of social and adaptive skills
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital20
ellendelbloggolo.blogspot.com
Sanfilippo Syndrome (cont.)
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital21
elle
ndel
blo
ggolo
.blo
gsp
ot.
comSevere behavior problems such as:
- Sleep disturbance
- Uncontrolled hyperactivity
- Temper tantrums
- Destructive behavior
- Physical aggression
are common
Sanfilippo Syndrome (cont.)
Delays in diagnosis of MPS III are commondue to :
- Mild physical features
- Hyperactivity
- Slowly progressive neurologic disease
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital22
rareshare.org
MPS 1
MPS I is caused by mutations of the IUA
gene on chromosome 4p16.3 encoding α-L-
iduronidase
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital23
www.patienthelp.org
MPS1 (cont.)
Deficiency of α-L- iduronidase results in a
broad clinical spectrum, from severe Hurler
disease to mild Scheie diseases
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital24
www.patienthelp.org
Hurler Disease (MPS I)
This is a severe form of MPS I ,and it isprogressive disorder with multiple organ andtissue involvement that results in prematuredeath, usually by 10 yr of age
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital25
www.eyecalcs.com
Hurler Disease (cont.)
An infant with Hurler syndrome appears
normal at birth, but inguinal hernias are often
present
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital26
www.eyecalcs.com
Hurler Disease (cont.)
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital27
www.eyecalcs.com
Most patients have:
• Recurrent upper respiratory tract and
ear infections
• Noisy breathing
• Persistent copious nasal discharge
Hurler Disease (cont.)
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital28
www.eyecalcs.com
Cardiac involvement include:
• Valvular heart disease:
Mitral and Aortic valves incompetence
• Coronary artery narrowing
Obstructive airway disease, notably during sleep, may necessitate tracheotomy.
Hurler Disease (cont.)
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital29
www.eyecalcs.com
Most children with Hurler syndrome acquire
social but only limited language skills
because of :
• Developmental delay
• Combined conductive and neurosensory
hearing loss
• An enlarged tongue
Hurler Disease (cont.)
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital30
www.eyecalcs.com
Headache and sleep disturbance due to:
Progressive ventricular enlargement with
increased intracranial pressure caused by
communicating hydrocephalus
Hurler Disease (cont.)
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital31
www.eyecalcs.com
Common eye involvement include:
• Corneal clouding
• Glaucoma
• Retinal degeneration
Hurler Disease (cont.)
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital32
www.eyecalcs.com
Skeletal abnormalities include:
• Enlarged, coarsely trabeculated diaphyses
of the long bones
• Irregular metaphyses and epiphyses
Hurler Disease (cont.)
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital33
www.eyecalcs.com
Radio-graphs show a
characteristic skeletal
dysplasia known as
dysostosis multiplex
The earliest radiographic
signs are thick ribs and
ovoid vertebral bodies
http://www.keywordpicture.com/keyword/arthrogryposis%20multiplex
http://www.maroteaux-lamy.com/Turkish/HCP/Bones.aspx
Hurler Disease (cont.)
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital34
ww
w.e
yec
alcs
.com
With progression of the disease macrocephaly
develops, with:
• Thickened calvarium
• Premature closure of lambdoid and
sagittal sutures
• Shallow orbits
Hurler Disease (cont.)
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital35
ww
w.e
yec
alcs
.com
Cont.
• Enlarged J-shaped sella
• Abnormal spacing of teeth with
dentigenous cysts
Hurler Disease (cont.) Diagnosis
Usually made between 6 and 24 mo of age
with evidence of:
– Hepatosplenomegaly
– Coarse facial features
– Corneal clouding
– Large tongue
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital36
ww
w.e
yec
alcs
.com
nlm.nih.gov
Hurler Disease (cont.) Diagnosis
-Prominent forehead
– Joint stiffness
– Short stature
– Skeletal dysplasia
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital37
ww
w.e
yec
alcs
.com
http://www.scripps.org/articles/99-frontal-bossing
http://www.nemours.org/service/medical/skeletal-dysplasia
http://doctorsgates.blogspot.ae
http://emedicine.medscape.com/article/951148-overview
Hurler Disease (cont.)
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital38
www.eyecalcs.com
Common causes of death:
• Obstructive airway disease
• Respiratory infection
• Cardiac complications
Hunter disease (MPS II)
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital39
Is an X-linked disorder caused by the
deficiency of iduronate-2-sulfatase (IDS)
flipper.diff.org
Hunter disease (MPS II) (cont.)
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital40
flipper.diff.org
The gene encoding IDS is mapped to Xq28.
Point mutations of the IDS gene have been
detected in about 80% of patients with MPS II
Hunter disease manifests almost exclusively in
males. it has been observed in a few females
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital41
www.treypurcell.com
Hunter disease (MPS II) (cont.)
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital42
flipper.diff.org
Patients with severe MPS II have features
similar to those of Hurler disease except for:
• Lack of corneal clouding
• Slower progression of:
Somatic and Central nervous system
(CNS) deterioration
Hunter disease (MPS II) (cont.)
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital43
flipper.diff.org
Clinical manifestations:
• Coarse facial features
• Short stature
• Dysostosis multiplex
• Joint stiffness
• Mental retardation manifest between
2 and 4 yr of age.
Hunter disease (MPS II) (cont.)
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital44
flipper.diff.org
The following may present
• Grouped skin papules
• Extensive Mongolian spots
• Chronic diarrhea
• Communicating hydrocephalus and
spastic paraplegia
Hunter disease (MPS II) (cont.)
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital45
Patients with the mild form have:
• Prolonged life span
• Minimal CNS involvement
• Slow progression of somatic deterioration
with preservation of intelligence in adult
life
flipper.diff.org
Hunter disease (MPS II) (cont.)
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital46
In severely affected patients:
• Extensive, slowly progressive neurologic
involvement
• Death, which usually occurs between 10
and 15 yr of age.
flipper.diff.org
Hunter disease (MPS II) (cont.)
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital47
In both the mild and severe forms:
• Airway involvement
• Valvular cardiac disease
• Hearing impairment
• Carpal tunnel syndrome
• Joint stiffness
Are common and can result in significant
loss of function
flipper.diff.org
Diagnosis of MPS
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital48
Any individual who is suspected of an MPS
disorder based on:
• Clinical features
• Radiographic results
• Urinary GAG screening tests
Should have a definitive diagnosis established
by enzyme assay
Differential diagnosis
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital49
1.Mucolipidoses
2.Oligosaccharidoses
In these conditions, the urinary excretion of
GAGs is not elevated
3. Neurodegenerative and dwarfing conditions
Mucopolysaccharidoses can be differentiate from
them by the present of:• Hurler- like facial features
• Joint contractures
• Dysostosis multiplex
• Elevated urinary GAG excretion
Treatment of MPS
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital50
• Hematopoietic stem cell transplantation
results in significant clinical improvement of
somatic disease in MPS I, II, and VI
• Enzyme replacement using recombinant
enzymes is approved for patients with MPS I,
MPS II, and MPS VI.
Hematopoietic stem cell transplantation
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital51
Clinical effects include :
• Increased life expectancy
• Resolution or improvement of growth
failure
• Upper airway obstruction
• Hepatosplenomegaly
• Joint stiffness
• Facial appearance
Hematopoietic stem cell transplantation (Cont.)
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital52
• Pebbly skin changes
• Obstructive sleep apnea
• Heart disease
• Communicating hydrocephalus
• Hearing loss
Hematopoietic stem cell transplantation (Cont.)
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital53
Enzyme activity in serum and urinary GAG
excretion is normalized
Transplantation prevents neurocognitive
degeneration
Hematopoietic stem cell transplantation (Cont.)
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital54
Transplantation does not correct :
• Existent cerebral damage
• Skeletal and ocular anomalies
Enzyme replacement
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital55
-It reduces :
• Organomegaly
• Number of episodes of sleep apnea
• Urinary GAG excretion
Enzyme replacement (Cont.)
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital56
- It ameliorates :
• rate of growth
• joint mobility
• Physical endurance.
Enzyme replacement (Cont.)
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital57
-The enzymes do not:
• Cross the blood-brain barrier
• Prevent deterioration of neurocognitive
involvement.
-This therapy is the domain for patients with
mild central nervous involvement
Prevention
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital58
• Primary prevention
Through genetic counseling
• Tertiary prevention
To avoid or treat complications remains the
mainstay of supportive pediatric care
Prevention (Cont.)
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital59
Multidisciplinary attention to:• Respiratory and cardiovascular complications
• Hearing loss
• Carpal tunnel syndrome
• Spinal cord compression
• Hydrocephalus, and other problems
Can greatly improve the quality of life for
patients and their families
Prevention (Cont.)
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital60
The progressive nature of clinical involvement
in MPS patients dictates the need for specialized
and coordinated evaluation
3/1/2015Mucopolysaccharidoses
Prof.Dr.Saad S Al Ani Khorfakkan Hospital61
noahstjohn.com